SAP v Versata decision threatens business method patents

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

SAP v Versata decision threatens business method patents

uspto-seal-45.gif

Business method patent owners were dealt a blow this week after the PTAB confirmed it will assume the “broadest reasonable interpretation” of a patent when considering if its claims are too far-reaching under new post-grant challenge proceedings

In the first-ever covered business method (CBM) review trial, the USPTO’s Patent Trial and Appeal Board (PTAB) found all five challenged claims in SAP v Versata invalid.

uspto-seal-200.gif

The PTAB concluded that Versata’s claims relating to a method and apparatus for pricing products and services are ineligible for patent protection under Section 101. Versata’s system arranges customers and products into a hierarchy and applies pricing adjustments to different groups.

The CBM review trial is a new post-grant patent challenge proceeding created under the AIA. Designed to reduce the number of overly broad business method patents, it allows those accused of infringing a patent covered under Section 18 of the AIA to challenge its validity through the USPTO’s appeals procedure rather than through the court system.

CBM review was introduced in September 2012. The USPTO will not accept any new petitions for CMB review on or after September 16, 2020.

Versata had argued that the terms for judging the validity of the claims should be based on a district court interpretation standard. But Administrative Patent Judges Sally Medley, Michael Tierney and Rama Elluru disagreed.

“The use of the broadest reasonable interpretation encourages patent owners to remove ambiguities and to narrow their claims by amendment, such that the inventor’s contribution to the art is expressed in clear, precise and unambiguous terms,” they said.

The dispute began in 2007, when Versata sued for infringement of US patent 6,553,350. A district court jury found that SAP had infringed the patent and awarded damages.

Both parties appealed to the Federal Circuit in October 2011. The appellate court affirmed the jury’s verdict and damages.

In September 2012, SAP filed a petition with the USPTO challenging claims 17 and 26 to 29 as being ineligible for patent protection. Versata claimed that SAP had failed to meet all three criteria for seeking a CBM review, but in February this year the PTAB disagreed and ordered that the review should go ahead.

more from across site and SHARED ros bottom lb

More from across our site

Find out which firms secured the most nominations for Managing IP’s Asia-Pacific Awards 2025, ahead of the winners being revealed on November 6
Raluca Vasilescu joins our ‘Five minutes with’ series to discuss patent mining and watercolour painting
Jan Phillip Rektorschek, founding partner at Pentarc in Germany, explains why the firm broke away from Taylor Wessing and discusses its plans for staying competitive
Royal Mail Group wins copyright and database right infringement case, in a dispute that can be linked to the history of postcodes in the UK
Managing partner Mark O’Donnell explains why people are at the centre of the Australian outfit’s investment focus and how being independent benefits the firm
IP is becoming one of the most significant drivers of major deals, and law firms are altering their practices to reflect the change
In the second in a new podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IPause, a network set up to support those experiencing (peri)menopause
Firms are adapting litigation strategy as Brazil’s unique legal system and technical expertise have made preliminary injunctions a key tool in global patent disputes
A ruling on confidentiality by the the England and Wales Court of Appeal and an intervention from the US government in the InterDigital v Disney litigation were also among top talking points
Moore & Van Allen hires former Teva counsel Larry Rickles to help expand the firm’s life sciences capabilities
Gift this article